Opinion

Video

Unmet Needs and Clinical Data with Hepatic Artery Infusion in Intrahepatic Cholangiocarcinoma

Author(s):

Ryan Merkow, MD, MS,Louise Catherine Connell, MB BCh BAO, BMedSc

Drs Connell and Merkow discuss the current treatment landscape in intrahepatic cholangiocarcinoma and review recent clinical data in that space.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
2 experts in this video
2 experts in this video
2 experts in this video
Related Content
Pancreatic Cancer | Image Credit: © magicmine – stock.adobe.com
March 12th 2025

Maintenance OSE2101 Plus FOLFIRI Meets Primary OS End Point in Advanced/Metastatic PDAC

Komal Jhaveri, MD, FACP, section head, Endocrine Therapy Research Program, clinical director, Early Drug Development Service, Patricia and James Cayne Chair for Junior Faculty, Memorial Sloan Kettering Cancer Center
February 17th 2025

Inavolisib Has a Favorable Risk-Benefit Profile for PIK3CA-Mutant, HR+ Metastatic Breast Cancer: With Komal Jhaveri, MD, FACP

The top 5 OncLive videos of the week cover insights in TGCT, NSCLC, TNBC, AML, and MDS.
March 9th 2025

Five Under 5: Top Oncology Videos for the Week of 3/2

Mark B. Geyer, MD, Adolescent and Young Adult Program leader, Adult Lymphoblastic Leukemia Program leader, Leukemia Service, chair, Quality Assessment, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center; Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
February 10th 2025

Ponatinib-Based Regimens Strengthen the Ph+ ALL Treatment Paradigm: With Mark B. Geyer, MD, and Elias Jabbour, MD

Gastric/GEJ Adenocarcinoma | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
March 7th 2025

Perioperative Durvalumab Plus Chemo Meets EFS End Point in Resectable Gastric/GEJ Cancer

HCC | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
March 7th 2025

Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC